ArticleThe Journal of clinical investigation2026

Ex vivo pretreatment with venetoclax boosts antileukemic efficacy of therapeutic γδ T cells in AML models.

Xingchi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.